Century Therapeutics Financial Overview
Century Therapeutics's market cap is currently $41.24M. The company's EPS TTM is $-0.4; its P/E ratio is ―; Century Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
